GBA1 and Parkinson disease: This approach might increase type I errors; however, our goal was to explore a wide range of clinical measurements including scales never used before in GBA1-PD (e.g., evaluating constipation), to gain novel insight on pathophysiology and provide new tentative findings that future studies conducted on larger cohorts could corroborate.